Search research articles
Contact Us
Filters
Showing results (191-200 of 231) with videos related to
Page
of 24
Sort By:
ACS Chemical Neuroscience
|
July 3, 2015
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Samuel D Banister, Michael Moir, Jordyn Stuart, et al.
Plos One
|
February 19, 2013
[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats
Hervé Boutin, Christian Prenant, Renaud Maroy, et al.
Journal of Medicinal Chemistry
|
February 17, 2017
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma
Qingqing Zhou, Athena F Phoa, Ramzi H Abbassi, et al.
ACS Chemical Neuroscience
|
April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
Cell Death Discovery
|
April 17, 2021
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells
Ariadna Recasens, Sean J Humphrey, Michael Ellis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 27, 2022
Quantification of the purinergic P2X<sub>7</sub> receptor with [<sup>11</sup>C]SMW139 improves through correction for brain-penetrating radiometabolites
Joachim Brumberg, Richard Aarnio, Anton Forsberg, et al.
Scientific Reports
|
August 15, 2020
Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
Jared S Katzeff, Fiona Bright, Kitty Lo, et al.
Biochemical Pharmacology
|
November 1, 2015
Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling
Athena F Phoa, Stephen Browne, Fadi M S Gurgis, et al.
European Journal of Medicinal Chemistry
|
September 13, 2020
Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism
Renee Sokias, Eryn L Werry, Hei Wun Alison Cheng, et al.
ACS Chemical Neuroscience
|
August 26, 2017
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X<sub>7</sub> Receptor Antagonist
Shane M Wilkinson, Melissa L Barron, James O'Brien-Brown, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 231) with videos related to
Sort By:
Page
of 24
ACS Chemical Neuroscience
|
July 3, 2015
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
Samuel D Banister, Michael Moir, Jordyn Stuart, et al.
Plos One
|
February 19, 2013
[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats
Hervé Boutin, Christian Prenant, Renaud Maroy, et al.
Journal of Medicinal Chemistry
|
February 17, 2017
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma
Qingqing Zhou, Athena F Phoa, Ramzi H Abbassi, et al.
ACS Chemical Neuroscience
|
April 30, 2015
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
Samuel D Banister, Jordyn Stuart, Richard C Kevin, et al.
Cell Death Discovery
|
April 17, 2021
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells
Ariadna Recasens, Sean J Humphrey, Michael Ellis, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
September 27, 2022
Quantification of the purinergic P2X<sub>7</sub> receptor with [<sup>11</sup>C]SMW139 improves through correction for brain-penetrating radiometabolites
Joachim Brumberg, Richard Aarnio, Anton Forsberg, et al.
Scientific Reports
|
August 15, 2020
Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
Jared S Katzeff, Fiona Bright, Kitty Lo, et al.
Biochemical Pharmacology
|
November 1, 2015
Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling
Athena F Phoa, Stephen Browne, Fadi M S Gurgis, et al.
European Journal of Medicinal Chemistry
|
September 13, 2020
Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism
Renee Sokias, Eryn L Werry, Hei Wun Alison Cheng, et al.
ACS Chemical Neuroscience
|
August 26, 2017
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X<sub>7</sub> Receptor Antagonist
Shane M Wilkinson, Melissa L Barron, James O'Brien-Brown, et al.
Page
of 24